CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 123 enrolled
Drug / intervention
senofilcon A contact lenses made with a novel manufacturing technology +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05361304
NCT05361304N/ACompleted

Clinical Evaluation of Senofilcon A Contact Lenses Using a Novel Manufacturing Technology

Johnson & Johnson Vision Care, Inc.·interventional·Posted May 4, 2022·Updated Jul 13, 2023

In Brief

A clinical study evaluating senofilcon A contact lenses made with a novel manufacturing technology and senofilcon A contact lenses made with the current manufacturing technology for Visual Acuity. Completed, enrolled 123 participants across 6 sites.

Detailed Summary

This study is a feasibility, multi-site, randomized, double-masked, 2-arm parallel group design, 2-week dispensing study with weekly visits to evaluate visual acuity.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVisual Acuity
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedMay 4, 2022
Enrollment StartMay 16, 2022
Primary CompletionJul 5, 2022
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 4.2 years ago

Interventions

senofilcon A contact lenses made with a novel manufacturing technologydevice

TEST Lens

senofilcon A contact lenses made with the current manufacturing technologydevice

CONTROL Lens